Skip to main content
Equibles
INSP logo

INSP · Inspire Medical Systems, Inc.

Track INSP — free

Use INSP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$63.07 +1.55 (+2.52%) At close · Sep 2
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.78B
Shares
28.91M

INSP metrics

81 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$63.07
Market cap
$1.78B

Price action

19 metrics
Price change (1W)
+0.7%
Price change (30D)
+17.8%
Price change (3M)
+51.6%
Price change (6M)
-6.5%
Price change (YTD)
-33.3%
Price change (1Y)
-34.3%
Trailing year
Price change (5Y)
-72.6%
52-week high
$143.99
52-week low
$40.05
Change from 52-week high
-57.3%
Change from 52-week low
+53.6%
Annualized volatility
71.2%
Beta
1.1
RSI (14D)
59.7
Price vs SMA 50
+14.3%
Price vs SMA 200
-7.5%
Avg volume (3M)
861,523
Relative volume
0.4
Average dollar volume
$43.06M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
28.91M

Valuation

12 metrics
P / E (TTM)
13.6
Trailing earnings · reciprocal yield 7.4%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 50.5%
P / book
2.2
reciprocal yield 46.4%
FCF yield
6.6%
TTM · current market cap
Buyback yield
5.6%
P / FCF
15.2
reciprocal yield 6.6%
P / operating cash flow
11.3
reciprocal yield 8.8%
Earnings yield
7.6%

Historical valuation

8 metrics
P / E historical average (3Y)
138.6×
reciprocal yield 0.7%
P / E historical average (5Y)
138.6×
reciprocal yield 0.7%
EV / revenue historical average (3Y)
29.5×
reciprocal yield 3.4%
EV / revenue historical average (5Y)
28.4×
reciprocal yield 3.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
5.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
86.1%
Operating margin
6.0%
Trailing 12 months
Net margin
15.0%
Gross profit (TTM)
$774.11M
Operating profit (TTM)
$54.12M
Net income (TTM)
$135.04M
Trailing 12 months
Diluted EPS (TTM)
$4.53
FCF margin
13.0%
Effective tax rate
-94.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.01

Growth

11 metrics
Revenue growth YoY
-7.6%
Year over year
Net income growth YoY
+171.8%
Revenue (TTM)
$898.74M
Trailing 12 months
EPS growth YoY
+179.4%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+30.8%
Revenue CAGR (5Y)
+51.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+216.6%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
16.4%
Return on assets
14.6%
Debt / equity
—
Current ratio
8.6
EBITDA (TTM)
$71.35M
Free cash flow (TTM)
$117.09M
Quick ratio
6.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$127.76M
Total assets
$925.99M
Total debt
$21.40M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$157.07M
Capital expenditures (TTM)
$39.98M
R&D (TTM)
$99.68M
SG&A (TTM)
$620.30M
Stock compensation (TTM)
$119.39M
R&D / revenue
11.1%
Stock compensation / revenue
13.3%

Ownership (13F)

3 metrics
13F filers
277
13F filer change QoQ
-27
Institutional ownership
128.8%

Short interest

3 metrics
Short interest
15.1%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
83 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$57,347
Insider-sentiment score
54 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1609550 CUSIP 457730109 13F (30d) 222 filings 212 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)